Market Research Logo

Bulgaria Pharmaceuticals & Healthcare Report Q1 2018

Bulgaria Pharmaceuticals & Healthcare Report Q1 2018

BMI View: The cardiovascular disease segment of the Bulgarian pharmaceutical market represents a significant opportunity for growth. According to the Bulgarian National Statistics Institute, more than 70% of deaths each year are directly accountable to cardiovascular diseases. This therapeutic area is therefore a high priority for the Ministry of Health to improve treatment, which will likely result in further reimbursement changes to medicines in order to improve accessibility to medicines, both preventative and therapeutic.


BMI Industry View
Table: Headline Pharmaceuticals & Healthcare Forecasts (Bulgaria 2015-2021)
SWOT
Industry Forecast
Pharmaceutical Market Forecast
Table: Pharmaceutical Sales, Historical Data And Forecasts (Bulgaria 2013-2021)
Healthcare Market Forecast
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Bulgaria 2013-2021)
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Bulgaria 2013-2021)
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Bulgaria 2013-2021)
Prescription Drug Market Forecast
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Bulgaria 2013-2021)
Patented Drug Market Forecast
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Bulgaria 2013-2021)
Generic Drug Market Forecast
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Bulgaria 2013-2021)
OTC Medicine Market Forecast
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Bulgaria 2013-2021)
Pharmaceutical Trade Forecast
Table: Pharmaceutical Trade Data And Forecasts (Bulgaria 2015-2021)
Table: Pharmaceutical Trade Data And Forecasts local currency (Bulgaria 2015-2021)
Industry Risk/Reward Index
Europe - Central And Eastern Europe Pharmaceuticals: Most Attractive Emerging Market
Bulgaria - Q1 2018
Regulatory Review
Intellectual Property Issues
Pricing Regime
Reimbursement Regime
Market Overview
Healthcare Sector
Table: Healthcare Resources (Bulgaria 2011-2016)
Table: Healthcare Personnel (Bulgaria 2011-2016)
Table: Healthcare Activity (Bulgaria 2011-2016)
Table: NHIF Budget, 2017
Table: Bulgarian National Health Insurance Fund Revenues (BGN 000s), 2015
Research & Development
Table: Members Of ARPharM, 2014
Clinical Trials
Epidemiology
Table: Cancer Incidence Rates, 2012-2035
Competitive Landscape
Research-Based Industry
Table: Multinational Market Activity
Generic Drugmakers
Pharmaceutical Retail Sector
Company Profile
Sopharma
Demographic Forecast
Demographic Outlook
Table: Population Headline Indicators (Bulgaria 1990-2025)
Table: Key Population Ratios (Bulgaria 1990-2025)
Table: Urban/Rural Population & Life Expectancy (Bulgaria 1990-2025)
Table: Population By Age Group (Bulgaria 1990-2025)
Table: Population By Age Group % (Bulgaria 1990-2025)
Glossary
Methodology
Pharmaceutical Expenditure Forecast Model
Healthcare Expenditure Forecast Model
Notes On Methodology
Risk/Reward Index Methodology
Table: Indicators - Rationale And Sources

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report